7
Participants
Start Date
February 15, 2023
Primary Completion Date
February 2, 2026
Study Completion Date
February 2, 2026
EBFAHF-2
EBFAHF-2 is a 0.55g capsule that is easy to swallow. The quality, safety and consistency of EBFAHF-2 are established per FDA guidance under a botanical drug title. Low dose (maximum of 2 capsules bid) and full dose (maximum of 5 capsules bid). Weight based dosing will ensure an equivalent amount is given to each individual.
Placebo
Placebo capsules made of cornstarch
Icahn School of Medicine at Mount Sinai, New York
Icahn School of Medicine at Mount Sinai
OTHER